top of page


Strategic Intelligence: Decoding NHS Prescribing Signals for Commercial Excellence
1. Introduction: Observed System Behavior In the UK pharmaceutical market, commercial discussions often begin with sales performance and market share. Yet NHS Primary Care prescribing data contains monthly signals that are not forecasts; they are observed system behavior. By the time commercial data hardens the narrative, prescribing patterns have often already evolved. The advantage lies not in reacting faster, but in recognizing change earlier. 2. Commercial Movement vs. Be

Erhan Alkan
Feb 113 min read


How Market Access Teams Work with Merlinn Insights
🔷How Market Access Teams work with Merlinn Insights How do you track the real-world impact of your access decisions post-launch? Closing the gap between clinical evidence and healthcare system realities is essential — not only to secure access, but to ensure it remains sustainable over time. This visual illustrates how Market Access teams use tools like Merlinn Insights to transform NHS primary care prescribing data into strategic understanding, helping keep access decisions

Erhan Alkan
Feb 51 min read


How Business Development Teams Use Merlinn
𝐁𝐮𝐬𝐢𝐧𝐞𝐬𝐬 𝐃𝐞𝐯𝐞𝐥𝐨𝐩𝐦𝐞𝐧𝐭 𝐝𝐞𝐜𝐢𝐬𝐢𝐨𝐧𝐬 𝐚𝐫𝐞 𝐨𝐟𝐭𝐞𝐧 𝐦𝐚𝐝𝐞 𝐥𝐨𝐧𝐠 𝐛𝐞𝐟𝐨𝐫𝐞 𝐞𝐱𝐞𝐜𝐮𝐭𝐢𝐨𝐧 𝐛𝐞𝐠𝐢𝐧𝐬. At this stage, the key questions are 𝐧𝐨𝐭 𝐚𝐛𝐨𝐮𝐭 𝐭𝐚𝐜𝐭𝐢𝐜𝐬, but about 𝐰𝐡𝐞𝐭𝐡𝐞𝐫 𝐝𝐞𝐦𝐚𝐧𝐝 𝐢𝐬 𝐬𝐭𝐚𝐛𝐥𝐞, 𝐡𝐨𝐰 𝐛𝐞𝐡𝐚𝐯𝐢𝐨𝐮𝐫 𝐞𝐯𝐨𝐥𝐯𝐞𝐬 𝐨𝐯𝐞𝐫 𝐭𝐢𝐦𝐞, and 𝐰𝐡𝐞𝐫𝐞 𝐮𝐧𝐜𝐞𝐫𝐭𝐚𝐢𝐧𝐭𝐲 𝐚𝐜𝐭𝐮𝐚𝐥𝐥𝐲 𝐥𝐢𝐞𝐬. In this article, I explain how 𝐌𝐞𝐫𝐥𝐢𝐧𝐧 𝐬𝐮𝐩𝐩𝐨𝐫𝐭𝐬 𝐁𝐮𝐬𝐢𝐧𝐞𝐬𝐬 𝐃𝐞𝐯

Erhan Alkan
Jan 201 min read
bottom of page
